Home » Drug Delivery » Injectable Drug Delivery » Dual Chamber Syringes & Injectors to 2022

Dual Chamber Syringes & Injectors to 2022


Chart_Collage_160   Published September 2015 •  Catalog no. DCJ222R  •  Price US $2,850


 

In terms of formulation market share gains, lyophilized injectable drugs are the fastest growing drug formulation segment. From 1990 to 1998 the share of newly approved lyophilized drugs as a share of all injectable/infusible drugs was 11.9%. In 2011, it was 41% and in 2013, injectable/infusible drugs requiring reconstitution made up half of all new approvals. Because a significant number of these drugs are developed for self-administration, they present special challenges for developers. Dual chamber syringes & injectors – designed to simplify reconstitution without patient handling of drug or diluent – have become the mainstay delivery option for this class of drugs. As lyophilized injectables continue to increase in number and market share, dual chamber syringes and injectors will experience double-digit annual unit growth.
Titles in this Series

Autoinjectors to 2024

Prefilled Syringes

Pen Injectors

Dual Chamber Syringes

High Viscosity Injectables

Bar_Graph  Dual Chamber Syringes and Injectors to 2022 Report Prospectus (Download PDF)

Blue document Dual Chamber Syringes and Injectors to 2022 Report Order Form (Download PDF)


What You Will Learn

• What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?
• What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?
• What are the key dual chamber device selection factors, technologies and market development issues?
• What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2022?
• What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?
• How important are pharma-device alliances and design partnerships on dual chamber injection devices?
• What is the impact of economic, technology, and regulatory factors?


Summary of Contents

Executive SummaryInjectable Drug Market Dynamics

Evolution in Device Design
Formulation Factors
Product Specific Device Development
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Formulation and Dosing
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market Drivers

The Dual Chamber Injection Device Ecosystem

Dual Chamber Cartridges
Dual Chamber Injectors
Dual Chamber Syringes

Dual Chamber Syringe & Injector Device Assessments

Product-Specific Devices
Specialty Devices
OEM Devices

Therapeutic Segments – Market Data & Forecasts

Glycemic Control
Hereditary Conditions
Hormone Replacement
Infectious Disease
Metabolic Conditions
Oncology
Reproductive Health
Other Therapeutic Segments

Market Factors

Device Product Strategies
Device Economics
Product Branding
Direct-to-Consumer Marketing
Managed Care Trends

Company Profiles